Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Losmapimod

Losmapimod

Losmapimod structure

Losmapimod 

structure
  • CAS No:

    585543-15-3

  • Formula:

    C22H26FN3O2

  • Chemical Name:

    Losmapimod

  • Synonyms:

    3-Pyridinecarboxamide,6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-;6-[5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide;6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)nicotinamide;GW 856553X;Losmapimod;GSK-AHAB;SB 856553;GW 856553;1201684-97-0

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Losmapimod is a selective, potent, and orally active p38 MAPK inhibitor with pKis of 8.1 and 7.6 for p38α and p38β, respectively.


6-[5-[(cyclopropylamino)-oxomethyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide is a phenylpyridine.|Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.|Losmapimod is an orally bioavailable inhibitor of the alpha and beta isoforms of p38 mitogen-activated protein kinase (MAPK), with potential immunomodulating and anti-inflammatory activities. Upon oral administration, losmapimod inhibits the activity of p38alpha/beta MAPK, thereby preventing p38alpha/beta MAPK-mediated signaling. This may result in the inhibition of the production of proinflammatory cytokines. p38 MAPK, a serine/threonine protein kinase, plays an important role in regulating the transcription and translation of cytokines involved in inflammation including tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-1, IL-6 and IL-8.

Losmapimod Basic Attributes

383.46

383.46

F2DQF16BXE

C96532

Characteristics

71.1

3.8

1.2±0.1 g/cm3

529.37ºC at 760 mmHg

274.0±30.1 °C

1.582

Safety Information

P201, P202, P281, P308+P313, P405, P501

H361

|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory.

Drug Information

6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide

Losmapimod Use and Manufacturing

Human drugs -> Rare disease (orphan)

Computed Properties

Molecular Weight:383.5
XLogP3:3.8
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:6
Exact Mass:383.20090524
Monoisotopic Mass:383.20090524
Topological Polar Surface Area:71.1
Heavy Atom Count:28
Complexity:573
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Losmapimod

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.